MHI
IRWD icon

Miller Howard Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Miller Howard Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,023
Closed -$319K – 197
2023
Q2 		$319K Buy
30,023
+169
+0.6% +$1.82K 0.01% 170
2023
Q1 		$314K Buy
29,854
+39
+0.1% +$437 0.01% 169
2022
Q4 		$369K Buy
29,815
+6,422
+27% +$72.8K 0.01% 165
2022
Q3 		$242K Buy
23,393
+55
+0.2% +$624 0.01% 178
2022
Q2 		$269K Buy
+23,338
New +$275K 0.01% 177

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Miller Howard Investments's IRWD Position: Q3 2023 in Review

Miller Howard Investments sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 30,023 shares — an estimated $319K sold.

Miller Howard Investments first reported a position in IRWD in Q2 2022 and held it in 5 quarters. The position peaked at $369K in Q4 2022. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

  • Miller Howard Investments reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Miller Howard Investments sold 30,023 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $319K.
  • Miller Howard Investments first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Miller Howard Investments's Ironwood Pharmaceuticals position peaked at $369K in Q4 2022.
  • 248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Miller Howard Investments's 13F filing for Q3 2023, filed 18 Oct 2023.